Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer

INTRODUCTION: Dysphagia is a common, dose-limiting toxicity of combined chemoradiotherapy (CT/RT) in patients with locally advanced non-small cell lung cancer (NSCLC). This study assessed the efficacy and safety of palifermin in reducing dysphagia from CT/RT followed by consolidation chemotherapy (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Schuette, Wolfgang, Krzakowski, Maciej J., Massuti, Bartomeu, Otterson, Gregory A., Lizambri, Richard, Wei, Helen, Berger, Dietmar P., Chen, Yuhchyau
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4284819/
https://ncbi.nlm.nih.gov/pubmed/22011667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31822f6526
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados